Patent · US Active

Antibodies directed to Fc gamma receptor IIB and Fc epsilon receptor

US10730946B2 · kind B2 · utility

1Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2015
Grant dateAug 4, 2020
Priority date
Expiry dateOct 8, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are recognition molecules that bind with a first binding domain to the Fc epsilon receptor (FcεeR) and with a second binding domain to the Fc gamma receptor IIB (FcyRIIB), as well as uses for such recognition molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.